Highlights
NASDAQ: CKPT       Checkpoint Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
3.40   -0.11 (3.13%)  3.015 - 3.40  4,966,812

Overview

 
Avg Volume (4 weeks):1,696,963
4 Weeks Range:2.06 - 4.50
4 Weeks Price Volatility (%):
54.92%
52 Weeks Range:1.05 - 4.50
52 Weeks Price Volatility (%):
68.12%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). Checkpoint emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP).

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2010  3947  233  3092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 106.84-3.50 
 LK 1.38+1.38 
 KODK 12.11+1.41 
 ONTX 0.322+0.072 
 GE 6.88-0.17 
 SAVA 10.07+2.98 
 SQQQ 27.48+1.06 
 WFC 25.13+0.02 
 TSLA 442.15+18.72 
 RIG 1.06-0.05 
PARTNERS & BROKERS